London, UK-based biotechnology company that supports the agriculture sector by equipping crops with genetic defenses against disease
Resurrect Bio has raised €16M across 2 funding rounds from 6 investors, most recently a Series A round in May 2026. Based in London, UK; active in Agritech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-15 | Series A | €8.8M | AgFunder,Calculus Capital,Corteva,Pymwymic,Synbioven,UKI2S | View deal → |
| 2026-02-20 | Series A | €6.9M | AgFunder,Calculus Capital,Corteva,Pymwymic,Synbioven,UKI2S | View deal → |
